Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects

被引:112
作者
Rohwedel, J
Guan, K
Hegert, C
Wobus, AM [1 ]
机构
[1] IPK Gatersleben, In Vitro Differentiat Grp, D-06466 Gatersleben, Germany
[2] Med Univ Lubeck, Dept Med Mol Biol, D-23538 Lubeck, Germany
关键词
mouse; embryonic stem cells; differentiation; gene expression patterns; cytotoxicity; embryotoxicity; mutagenicity;
D O I
10.1016/S0887-2333(01)00074-1
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Primary cultures or established cell lines of vertebrates are commonly used to analyse the mutagenic, embryotoxic or teratogenic potential of environmental factors, drugs and xenobiotics in vitro. However, these cellular systems do not include developmental processes from early embryonic stages up to terminally differentiated cell types. An alternative approach has been offered by permanent lines of pluripotent stein cells of embryonic origin, such as embryonic carcinoma (EC), embryonic stem (ES) and embryonic germ (EG) cells. The undifferentiated stem cell lines are characterized by nearly unlimited self-renewal capacity and have been shown to differentiate in vitro into cells of all three primary germ layers. Pluripotent embryonic stem cell lines recapitulate cellular developmental processes and gene expression patterns of early embryogenesis during in vitro differentiation, data which are summarized in this review. In addition, recent studies are presented which investigated mutagenic, cytotoxic and embryotoxic effects of chemical substances using in vitro systems of pluripotent embryonic stein cells. Furthermore, an outlook is given on future molecular technologies using embryonic stem cells in developmental toxicology and embryotoxicology. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:741 / 753
页数:13
相关论文
共 127 条
[31]  
GUAN K, 2001, IN PRESS CELL TISSUE
[32]   Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro [J].
Helgason, CD ;
Sauvageau, G ;
Lawrence, HJ ;
Largman, C ;
Humphries, RK .
BLOOD, 1996, 87 (07) :2740-2749
[33]   Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis [J].
Hescheler, J ;
Fleischmann, BK ;
Lentini, S ;
Maltsev, VA ;
Rohwedel, J ;
Wobus, AM ;
Addicks, K .
CARDIOVASCULAR RESEARCH, 1997, 36 (02) :149-162
[34]   USE OF THE FLUORESCENCE-ACTIVATED CELL SORTER (FACS) FOR IN-VITRO ASSAYS OF DEVELOPMENTAL TOXICITY [J].
HOOGHE, RJ ;
OOMS, D .
TOXICOLOGY IN VITRO, 1995, 9 (03) :349-354
[35]  
HSIE AW, 1979, MAMMALIAN CELL MUTAG
[36]  
HULME LM, 1990, TOXICOL IN VITRO, V4, P569
[37]   EVIDENCE FOR INVOLVEMENT OF ACTIVIN-A AND BONE MORPHOGENETIC PROTEIN-4 IN MAMMALIAN MESODERM AND HEMATOPOIETIC DEVELOPMENT [J].
JOHANSSON, BM ;
WILES, MV .
MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) :141-151
[38]   HEMATOPOIETIC COMMITMENT DURING EMBRYONIC STEM-CELL DIFFERENTIATION IN CULTURE [J].
KELLER, G ;
KENNEDY, M ;
PAPAYANNOPOULOU, T ;
WILES, MV .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :473-486
[39]  
KIMMEL GL, 1982, TERATOGEN CARCIN MUT, V2, P221, DOI 10.1002/1520-6866(1990)2:3/4<221::AID-TCM1770020304>3.0.CO
[40]  
2-7